Cargando…
The use of dexamethasone in the treatment of COVID-19
Autores principales: | Lester, Mohammed, Sahin, Ali, Pasyar, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343652/ https://www.ncbi.nlm.nih.gov/pubmed/32754312 http://dx.doi.org/10.1016/j.amsu.2020.07.004 |
Ejemplares similares
-
Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials
por: Kow, Chia Siang, et al.
Publicado: (2023) -
Evaluating the effectiveness of local dexamethasone injection in pregnant women with carpal tunnel syndrome
por: Moghtaderi, Ali Reza, et al.
Publicado: (2011) -
Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data
por: Sharma, Abhay
Publicado: (2021) -
Changes in immune cell populations following KappaMab, lenalidomide and low‐dose dexamethasone treatment in multiple myeloma
por: Norton, Samuel E, et al.
Publicado: (2023) -
The Effect of Ondansetron and Dexamethasone on Nausea and Vomiting under Spinal Anesthesia
por: Kalani, Navid, et al.
Publicado: (2017)